Values First Advisors »

Cytokinetics shares owned by Values First Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Values First Advisors from 13F filings

Historical chart of Values First Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Values First Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Values First Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $54k 1.0k 52.81
2023-03-31 $78k 2.2k 35.19

More positions owned by Values First Advisors

Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares U S Etf Tr Short Duration B (NEAR)
Emergent BioSolutions (EBS)
Ensign (ENSG)
Mid-America Apartment (MAA)
Synovus Finl Corp Com New (SNV)
Hackett (HCKT)
LeMaitre Vascular (LMAT)
National Retail Properties (NNN)
Cincinnati Financial Corporation (CINF)

View all positions for Values First Advisors

Top funds holding Cytokinetics

BlackRock
Vanguard Group
FMR
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
Geode Capital Management
Rtw Investments
T. Rowe Price Associates
Polar Capital Holdings
Pentwater Capital Management
Marshall Wace
Pictet Asset Management Holding SA
Armistice Capital
Citadel Advisors

View all funds holding Cytokinetics